Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Biotechnology Reagents & Kits Market, By Kit Type
7.1. Biotechnology Reagents & Kits Market, by Kit Type, 2020-2030
7.1.1. Purification Kits
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Amplification Kits
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Detection Kits
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Isolation Kits
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Biotechnology Reagents & Kits Market, By Technology
8.1. Biotechnology Reagents & Kits Market, by Technology, 2020-2030
8.1.1. LAMP Technology
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. PCR
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Cell Culture
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Sequencing
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. Chromatography
8.1.5.1. Market Revenue and Forecast (2016-2030)
8.1.6. Electrophoresis
8.1.6.1. Market Revenue and Forecast (2016-2030)
8.1.7. Flow Cytometry
8.1.7.1. Market Revenue and Forecast (2016-2030)
8.1.8. Other Technologies
8.1.8.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Biotechnology Reagents & Kits Market, By Tested Parameters
9.1. Biotechnology Reagents & Kits Market, by Tested Parameters, 2020-2030
9.1.1. DNA
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. RNA
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Enzymes
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Proteins
9.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Biotechnology Reagents & Kits Market, By Micro-Organisms
10.1. Biotechnology Reagents & Kits Market, by Micro-Organisms, 2020-2030
10.1.1. Bacteria
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Virus
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Fungi
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Parasites
10.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Biotechnology Reagents & Kits Market, By Purpose
11.1. Biotechnology Reagents & Kits Market, by Purpose, 2020-2030
11.1.1. On-Site
11.1.1.1. Market Revenue and Forecast (2016-2030)
11.1.2. Laboratory
11.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 12. Global Biotechnology Reagents & Kits Market, By End-use
12.1. Biotechnology Reagents & Kits Market, by End-use, 2020-2030
12.1.1. Healthcare
12.1.1.1. Market Revenue and Forecast (2016-2030)
12.1.2. Food & Agriculture
12.1.2.1. Market Revenue and Forecast (2016-2030)
12.1.3. Natural Resources & Environment
12.1.3.1. Market Revenue and Forecast (2016-2030)
12.1.4. Industrial Processing
12.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 13. Global Biotechnology Reagents & Kits Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.1.2. Market Revenue and Forecast, by Technology (2016-2030)
13.1.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.1.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.1.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.1.6. Market Revenue and Forecast, by End-use (2016-2030)
13.1.7. U.S.
13.1.7.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.1.7.2. Market Revenue and Forecast, by Technology (2016-2030)
13.1.7.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.1.7.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.1.7.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.1.7.6. Market Revenue and Forecast, by End-use (2016-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.1.8.2. Market Revenue and Forecast, by Technology (2016-2030)
13.1.8.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.1.8.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.1.8.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.1.8.6. Market Revenue and Forecast, by End-use (2016-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.2.2. Market Revenue and Forecast, by Technology (2016-2030)
13.2.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.2.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.2.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.2.6. Market Revenue and Forecast, by End-use (2016-2030)
13.2.7. UK
13.2.7.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.2.7.2. Market Revenue and Forecast, by Technology (2016-2030)
13.2.7.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.2.7.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.2.7.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.2.7.6. Market Revenue and Forecast, by End-use (2016-2030)
13.2.8. Germany
13.2.8.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.2.8.2. Market Revenue and Forecast, by Technology (2016-2030)
13.2.8.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.2.8.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.2.8.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.2.8.6. Market Revenue and Forecast, by End-use (2016-2030)
13.2.9. France
13.2.9.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.2.9.2. Market Revenue and Forecast, by Technology (2016-2030)
13.2.9.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.2.9.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.2.9.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.2.9.6. Market Revenue and Forecast, by End-use (2016-2030)
13.2.10. Rest of Europe
13.2.10.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.2.10.2. Market Revenue and Forecast, by Technology (2016-2030)
13.2.10.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.2.10.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.2.10.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.2.10.6. Market Revenue and Forecast, by End-use (2016-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.3.2. Market Revenue and Forecast, by Technology (2016-2030)
13.3.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.3.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.3.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.3.6. Market Revenue and Forecast, by End-use (2016-2030)
13.3.7. India
13.3.7.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.3.7.2. Market Revenue and Forecast, by Technology (2016-2030)
13.3.7.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.3.7.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.3.7.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.3.7.6. Market Revenue and Forecast, by End-use (2016-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.3.8.2. Market Revenue and Forecast, by Technology (2016-2030)
13.3.8.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.3.8.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.3.8.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.3.8.6. Market Revenue and Forecast, by End-use (2016-2030)
13.3.9. Japan
13.3.9.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.3.9.2. Market Revenue and Forecast, by Technology (2016-2030)
13.3.9.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.3.9.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.3.9.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.3.9.6. Market Revenue and Forecast, by End-use (2016-2030)
13.3.10. Rest of APAC
13.3.10.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.3.10.2. Market Revenue and Forecast, by Technology (2016-2030)
13.3.10.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.3.10.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.3.10.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.3.10.6. Market Revenue and Forecast, by End-use (2016-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.4.2. Market Revenue and Forecast, by Technology (2016-2030)
13.4.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.4.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.4.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.4.6. Market Revenue and Forecast, by End-use (2016-2030)
13.4.7. GCC
13.4.7.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.4.7.2. Market Revenue and Forecast, by Technology (2016-2030)
13.4.7.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.4.7.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.4.7.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.4.7.6. Market Revenue and Forecast, by End-use (2016-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.4.8.2. Market Revenue and Forecast, by Technology (2016-2030)
13.4.8.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.4.8.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.4.8.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.4.8.6. Market Revenue and Forecast, by End-use (2016-2030)
13.4.9. South Africa
13.4.9.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.4.9.2. Market Revenue and Forecast, by Technology (2016-2030)
13.4.9.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.4.9.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.4.9.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.4.9.6. Market Revenue and Forecast, by End-use (2016-2030)
13.4.10. Rest of MEA
13.4.10.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.4.10.2. Market Revenue and Forecast, by Technology (2016-2030)
13.4.10.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.4.10.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.4.10.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.4.10.6. Market Revenue and Forecast, by End-use (2016-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.5.2. Market Revenue and Forecast, by Technology (2016-2030)
13.5.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.5.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.5.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.5.6. Market Revenue and Forecast, by End-use (2016-2030)
13.5.7. Brazil
13.5.7.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.5.7.2. Market Revenue and Forecast, by Technology (2016-2030)
13.5.7.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.5.7.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.5.7.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.5.7.6. Market Revenue and Forecast, by End-use (2016-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Kit Type (2016-2030)
13.5.8.2. Market Revenue and Forecast, by Technology (2016-2030)
13.5.8.3. Market Revenue and Forecast, by Tested Parameters (2016-2030)
13.5.8.4. Market Revenue and Forecast, by Micro-Organisms (2016-2030)
13.5.8.5. Market Revenue and Forecast, by Purpose (2016-2030)
13.5.8.6. Market Revenue and Forecast, by End-use (2016-2030)
Chapter 14. Company Profiles
14.1. New England Biolabs
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Illumina, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Agilent Technologies, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Bio-Rad Laboratories
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. F. Hoffmann-La Roche Ltd.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Merck KGaA
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Promega Corp.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Takara Bio, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. LGC Ltd.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Toyobo Co. Ltd.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
Glossary of Terms